Washington, D.C. 20549







Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 4, 2017



InfuSystem Holdings, Inc.

(Exact name of registrant as specified in its charter)




Delaware   001-35020   20-3341405

(State or other jurisdiction of

incorporation or organization)

  (Commission File Number)   (I.R.S. Employer Identification No.)

31700 Research Park Drive

Madison Heights, Michigan 48071

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (248) 291-1210

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  




Item 2.02. Results of Operations and Financial Condition

On August 4, 2017, InfuSystem Holdings, Inc. issued a press release announcing that the Company will disclose its financial results for the second quarter ended June 30, 2017 on Wednesday, August 9, 2017 after the market close. The Company will also conduct a conference call for all interested investors on Wednesday, August 9, 2017, at 4:30 p.m. Eastern Time. A copy of the press release is furnished as an exhibit to this Form 8-K.


Item 9.01. Financial Statements and Exhibits

(a) Financial statements:


(b) Pro forma financial information:


(c) Shell company transactions:


(d) Exhibits


          99.1    Press Release of InfuSystem Holdings, Inc. dated August 4, 2017.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



/s/ Trent N. Smith

  Trent N. Smith
  Executive Vice-President,
  Chief Accounting Officer and Corporate Controller

Dated: August 4, 2017

Index to Exhibits


Exhibit No.



Exhibit 99.1    Press Release of InfuSystem Holdings, Inc. dated August 4, 2017.